The CADTH Scientific Advice Program is a voluntary, non-binding, and confidential fee-for-service consultation. Through this Program, pharmaceutical companies are provided with advice on their early drug development plans from a Canadian health technology assessment perspective.
Resuming CADTH Scientific Advice Activities
We are pleased to announce that the CADTH Scientific Advice Program will resume activities on October 1, 2020. All Scientific Advice meetings will be held virtually until further notice. Applications for Scientific Advice meetings being planned in late February 2021 and onwards can be submitted online starting October 1, 2020, and will be reviewed for eligibility and availability of meeting dates in the order that they are submitted. Please note that available time periods may fill quickly and CADTH may not be able to accommodate all requests. If you have any questions, please contact email@example.com.
Published : October 1, 2020